Page 261 - bandung_Neat

Judul : Bio Farma ensures Indonesians given priority in vaccine
distribution

Nama Media : antaranews.com

Tanggal : 12 Agustus 2020
Halaman/URL : https://kalsel.antaranews.com/berita/190810/bio-farma-
ensures-indonesians-given-priority-in-vaccine-distribution

Tipe Media : Online

PT Bio Farma Director Honesti Basyir has
made assurance that Indonesians will be
prioritized during the distribution of the COVID-
19 vaccine after passing the clinical trial period
and securing permission for production.

"The priority is for domestic (use) first," Basyir
stated at the Padjajaran Institute Hospital in
Bandung, West Java, on Tuesday.
As per calculations, 160 million Indonesians
will be prioritized to receive the vaccine that
originated from China's Sinovac.
The Bio Farma director noted that each individual will have to be administered two doses of
the vaccination.

"Next year, the target is set to vaccinate 160 million members of the population, with each
individual receiving two doses, thereby translating to the fact that we will require to prepare
320 million doses," he stated.

Basyir noted that once the vaccination requirements for Indonesians were met, Bio Farma
will then consider exporting the vaccine to other countries.
Currently, the company is awaiting the conclusion of the clinical trial process as well as the
licensing phase from the Food and Drug Supervisory Agency (BPOM) that is targeted for
completion in January 2021.
Furthermore, Basyir stated that Bio Farma had an annual production capacity of 100 million
vaccines. By December 2020, the company will have a new building, thereby leading to
another 150 million doses being added to their annual production.

"The president is looking at a new building that can result in the added production of 150
million doses per year. It will be completed in December. Thus, in terms of capacity, we will
be ready (to produce) 250 million doses in December," he expounded.

In the meantime, President Joko Widodo was optimistic that the vaccine, still under the
clinical trial phase, would be able to tackle the COVID-19 pandemic in Indonesia while
prioritizing its citizens.

"We are optimistic that with the finding of the vaccine, we would be able to distribute
vaccines to all Indonesians," he added.